176 related articles for article (PubMed ID: 12534360)
41. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation.
McMasters RA; Saylors RL; Jones KE; Hendrix ME; Moyer MP; Drake RR
Hum Gene Ther; 1998 Oct; 9(15):2253-61. PubMed ID: 9794209
[TBL] [Abstract][Full Text] [Related]
42. Retrovirus-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter.
Braiden V; Nagayama Y; Iitaka M; Namba H; Niwa M; Yamashita S
Endocrinology; 1998 Sep; 139(9):3996-9. PubMed ID: 9724055
[TBL] [Abstract][Full Text] [Related]
43. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
Gao Ding Cheng ; An W; Dai J
Cell Res; 1999 Sep; 9(3):225-35. PubMed ID: 10520605
[TBL] [Abstract][Full Text] [Related]
44. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
[TBL] [Abstract][Full Text] [Related]
45. A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simplex virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro.
Vrionis FD; Wu JK; Qi P; Cano W; Cherington V
J Neurosurg; 1995 Oct; 83(4):698-704. PubMed ID: 7674020
[TBL] [Abstract][Full Text] [Related]
46. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
47. [Gene therapy of human pancreatic carcinoma by recombinant retroviral vector expressing herpes simplex virus thymidine kinase gene].
Li H; Liu T; Wang Z
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):345-7. PubMed ID: 8732088
[TBL] [Abstract][Full Text] [Related]
48. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
[TBL] [Abstract][Full Text] [Related]
49. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
[TBL] [Abstract][Full Text] [Related]
50. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
[TBL] [Abstract][Full Text] [Related]
51. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.
Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW
Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.
Majumdar AS; Zolotorev A; Samuel S; Tran K; Vertin B; Hall-Meier M; Antoni BA; Adeline E; Philip M; Philip R
Cancer Gene Ther; 2000 Jul; 7(7):1086-99. PubMed ID: 10917212
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of prodrugs ability to induce effective ablation of cells transduced with viral thymidine kinase gene.
Kuriyama S; Nakatani T; Masui K; Sakamoto T; Tominaga K; Yoshikawa M; Fukui H; Ikenaka K; Tsujii T
Anticancer Res; 1996; 16(5A):2623-8. PubMed ID: 8917361
[TBL] [Abstract][Full Text] [Related]
54. Ablation of tumor cells in vivo by direct injection of HSV-thymidine kinase retroviral vector and ganciclovir therapy.
Howard BD; Kalthoff H; Fong TC
Ann N Y Acad Sci; 1999 Jun; 880():352-65. PubMed ID: 10415879
[TBL] [Abstract][Full Text] [Related]
55. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells.
Yang L; Chiang Y; Lenz HJ; Danenberg KD; Spears CP; Gordon EM; Anderson WF; Parekh D
Hum Gene Ther; 1998 Mar; 9(5):719-28. PubMed ID: 9551619
[TBL] [Abstract][Full Text] [Related]
56. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
[TBL] [Abstract][Full Text] [Related]
57. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
Eastham JA; Chen SH; Sehgal I; Yang G; Timme TL; Hall SJ; Woo SL; Thompson TC
Hum Gene Ther; 1996 Mar; 7(4):515-23. PubMed ID: 8800746
[TBL] [Abstract][Full Text] [Related]
58. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir.
Yang L; Hwang R; Pandit L; Gordon EM; Anderson WF; Parekh D
Ann Surg; 1996 Sep; 224(3):405-14; discussion 414-7. PubMed ID: 8813269
[TBL] [Abstract][Full Text] [Related]
59. The efficacy of retroviral herpes simplex virus thymidine kinase gene transfer and ganciclovir treatment on the inhibition of melanoma growth in vitro and in vivo.
Slade N; Galetić I; Kapitanović S; Pavelić J
Arch Dermatol Res; 2001 Nov; 293(10):484-90. PubMed ID: 11820724
[TBL] [Abstract][Full Text] [Related]
60. Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy.
Ramesh R; Munshi A; Marrogi AJ; Freeman SM
Int J Cancer; 1999 Jan; 80(3):380-6. PubMed ID: 9935178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]